Clinical Trials in North Carolina

Showing 15141-15160 of 20,428 trials

Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin

NCT02429258

Effect of Dapagliflozin on 24-hour Blood Glucose in Type 2 Diabetes Patients Inadequately Controlled With Either Metformin Or Insulin

Type II Diabetes

AstraZeneca226 participantsStarted May 2015

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Huntington Park, California, United States +23 more locations

TERMINATEDPhase 238 miles

Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC

NCT00519831

RATIONALE: Drugs used in chemotherapy, such as vinflunine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some find tumor cells and help kill them or carry tumor-killing substances to them. Others interfere with the ability of tumor cells to grow and spread. Giving vinflunine together with cetuximab may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving vinflunine together with cetuximab works as second-line therapy in treating patients with stage IIIB or stage IV non-small cell lung cancer.

Lung Cancer

UNC Lineberger Comprehensive Cancer Center18 participantsStarted Aug 2007

Burlington, North Carolina, United States • Chapel Hill, North Carolina, United States

Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin

Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC

Find Trials by Condition in North Carolina

Stem Cell Related Donor Safety Study

Trisenox® in Women With Metastatic Endometrial Cancer

Safety and Efficacy of Topical Thrombin (Human) Grifols as an Adjunct to Hemostasis During Surgery

Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents

A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)

Axillary Lymph Node Preservation Surgery in Reducing Lymphedema in Patients With Breast Cancer

Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair

This Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS.

A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer

Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia

Study Comparing TVT With TVT-SECUR for the Treatment of Stress Urinary Incontinence

Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects

A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers

An Observational Study of Cholesterol in Coronary Arteries

Hyper- and Hypokalemic Periodic Paralysis Study

REal World EVidence for TrEAtment of HyperkaLemia in Emergency Department: Multicenter, Prospective, Observational Study

A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes

Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)